Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v2-EN
Language English English
Date Updated 2020-09-02 2020-07-23
Drug Identification Number 02240602 02240602
Brand name BUSULFEX BUSULFEX
Common or Proper name busulfex busulfex
Company Name OTSUKA PHARMACEUTICAL CO LTD OTSUKA PHARMACEUTICAL CO LTD
Ingredients BUSULFAN BUSULFAN
Strength(s) 60MG 60MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 6mg/mL, 10 mL vial 6mL
ATC code L01AB L01AB
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-09-01 2020-09-01
Actual discontinuation date 2020-09-01 2020-09-01
Remaining supply date 2020-10-01 2020-10-01
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments